Ananiti-malaria drug touted by President Trump as a"game changer" for COVID-19 showed no benefit, according to an analysis of patients hospitalized in Veterans Health Administration medical centers.
The analysis found the two primary outcomes for people treated with hydroxychloroquine were death and the need for mechanical ventilation.
The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed COVID-19 infections in all VA medical centers until April 11, 2020.
TVNL Comment: Read the second paragraph carefully. Self-anointed Dr. Trump is a charleton.
President-elect Donald Trump will nominate former presidential candidate and anti-vaccine activist Robert F. Kennedy Jr. to...
Arizona remained in a tense waiting game on Saturday for its election results, even as neighboring...
The war in the Gaza Strip is taking a catastrophic toll on children. At least 14,000...
Several professors at universities around the US are facing disciplinary actions in regard to their support...
